Detalhe da pesquisa
1.
A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models.
Pharm Res
; 38(6): 1093-1106, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961188
2.
Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma.
Cancer Sci
; 111(6): 1969-1978, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32302443
3.
FF-10832 enables long survival via effective gemcitabine accumulation in a lethal murine peritoneal dissemination model.
Cancer Sci
; 110(9): 2933-2940, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31278877
4.
FF-10502, an Antimetabolite with Novel Activity on Dormant Cells, Is Superior to Gemcitabine for Targeting Pancreatic Cancer Cells.
J Pharmacol Exp Ther
; 366(1): 125-135, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653962
5.
Dedifferentiated retroperitoneal liposarcoma spontaneously occurring in an aged SD rat.
J Toxicol Pathol
; 31(2): 141-146, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29750003
6.
An improved mouse orthotopic bladder cancer model exhibiting progression and treatment response characteristics of human recurrent bladder cancer.
Oncol Lett
; 19(1): 833-839, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31885717
7.
Investigation into metastatic processes and the therapeutic effects of gemcitabine on human pancreatic cancer using an orthotopic SUIT-2 pancreatic cancer mouse model.
Oncol Lett
; 15(3): 3091-3099, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29435042